Prenatal diagnostics is a procedure for
testing the fetus before birth to determine certain hereditary disorders
such as Down’s syndrome, genetic diseases, chromosome abnormalities,
neural tube defects, and other conditions. In case of high risk related
to the birth of a child, it can assist by conducting numerous procedures
of genetic testing common testing, and screening.
The global prenatal diagnostics market is
segmented on the basis of tests into Harmony PrenaTest, BambniTest,
NIFTY (Non-invasive fetal trisomy test), Verifi, informaSeq, informaSeq
Panorama, MaterniT21 PLUS, and VisibiliT.
In the report, Transparency Market Report
(TMR) presents a comprehensive analysis of drivers and restrictions in
the global prenatal diagnostics market. It also provides insight into
the major segments and regions of the market.
Global Prenatal Diagnostics Market: Trends and Prospects
The global prenatal diagnostics market is
driven by numerous factors such as growing demand for non-invasive
prenatal diagnostics, rise in detection rates of Down’s syndrome,
technology advancements, and the crucial one being increasing age of
mothers which develops the possibility and risk of chromosomal
abnormalities. However, strict regulatory framework and traditional
ethical outlook towards prenatal testing can limit the growth of the
prenatal diagnostics. In addition, non-invasive prenatal tests and
alternative screening and testing methods can also create hurdles for
the market growth.
On basis of tests, MaterniT21 plus
segment will largely contribute to the market share, and is expected to
lead the market during the forecast period. It is preferred over the
other tests in the category as it is the first of its kind diagnostic
system. Due to higher accuracy and safety panorama and verifi tests are
also high in demand and is projected to register a strong CAGR during
the forecast period. Moreover, increased market penetration and
aggressive marketing strategies by companies are further propelling the
growth of these tests.
Global Prenatal Diagnostics Market: Regional Analysis
The global prenatal diagnostics market is
segmented on the basis of geography into North America, Asia Pacific,
Europe, Latin America, and the Middle East and Africa. Among the
mentioned regions, North America is expected to lead the regional
segment. The factors leading to the growth of this region can be
attributed to growing efforts of coalitions between companies and
hospitals and increasing penetration of the testing procedures. In
addition, due to increase in the rate of high risk pregnancies and
rising average age for child bearing leading to development of
chromosomal disorders, the market is said to propel over the forecast
period. With increased penetration of companies and rising approvals by
the European commission organizations, the European market is
anticipated to thrive in terms of revenue.
The Middle East and Asia Pacific are
untapped territories for many established market players. With better
marketing strategies and positioning, major companies are planning to
venture in this region, thereby increasing the market growth. Moreover,
supportive government research initiatives, rising disposable income,
increasing paranoia of to-be mothers for the health of their child are
some of the factors supplementing the market growth of non-invasive
prenatal diagnostics.
Companies Mentioned in the Report
Some of the leading players in the global
prenatal diagnostics market are Hologic Inc., Sequenom, Inc.,
PerkinElmer, Inc., Ravgen, Inc., Sequenom Center for Molecular Medicine,
LLC, Abbott Molecular, Angle Plc., and TrovaGene, Inc.
No comments:
Post a Comment